Skip to main content

Ouimette Mike's Form 4 filing

Pliant Therapeutics, Inc. (PLRX) · filed Jan 25, 2023

Accession no.
0001140361-23-002785
Filed
Jan 25, 2023
Trade date
Jan 23, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $683.8K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ouimette MikeCIK 0001822619Officer (General Counsel & Corp. Sec'y)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 23, 2023Common StockMOption exerciseAcquired+10,000$11.86+$118,60015,947Direct
Jan 23, 2023Common StockMOption exerciseAcquired+10,000$24.32+$243,20025,947Direct
Jan 23, 2023Common StockSSaleDisposed−20,000$34.19−$683,8005,947Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 23, 2023Common StockMOption exerciseDisposed−10,000$0.00$077,000Direct
Jan 23, 2023Common StockMOption exerciseDisposed−10,000$0.00$098,240Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)